Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Mycobacterium avium infection can result in three different kinds of illness in humans

Through work carried out in connection with her PhD, Tone Bjordal Johansen has shown that Mycobacterium avium does not infect pigs via birds, as previously believed. M. avium can be divided into several subspecies, and the research shows that birds are infected by one particular subspecies, whereas pigs and humans are infected by another.

4 Feb 2010

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Antiviral drugs block influenza A viruses from reproducing and spreading by attaching to a site within a proton channel necessary for the virus to infect healthy cells, according to a research project led by Iowa State University's Mei Hong and published in the Feb. 4 issue of the journal Nature.

4 Feb 2010

Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys' summer camp

Providing preventive Tamiflu and educating and emphasizing the need for repeated hand sanitizer use and disinfectant spray helped stop the spread of H1N1 influenza at a boys' summer camp in northern Alabama, according the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

4 Feb 2010

Vaccination against seasonal influenza produces protective immune response in infants

Vaccination against seasonal influenza is safe and produces a protective immune response in infants as young as 6 to 12 weeks, concludes a study in the February issue of The Pediatric Infectious Disease Journal.

4 Feb 2010

Mandatory flu shot program increases vaccination rate to more than 98% in BJC HealthCare

Making flu shots mandatory in 2008 dramatically increased the vaccination rate among St. Louis-based BJC HealthCare's nearly 26,000 employees to more than 98 percent, according to a report now online in the journal Clinical Infectious Diseases.

4 Feb 2010

Tough economy adds stress to hospitals; Community health centers help fill gaps

Hospitals get mixed marks while many suffer from the effects of the struggling economy. Meanwhile, community health centers increasingly provide more care and help fill in health care gaps.

4 Feb 2010

New York Times examines WHO process for getting H1N1 vaccines to countries in need

The New York Times examines the WHO's role as a "clearinghouse" for getting the H1N1 (swine flu) vaccine to lower income nations. Though H1N1 has died down in North America and many wealthier nations "are trying to get rid of their [vaccine] surpluses," the virus continues to circulate in regions of North Africa, Central Asia and Eastern Europe, according to the newspaper.

3 Feb 2010

BD Diagnostics launches Be a Flu Fighter initiative to increase awareness and prevent influenza

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the Be a Flu Fighter initiative, aimed at increasing awareness and prevention of influenza.

From BD (Becton, Dickinson and Company) 3 Feb 2010

DLA stocks USNS Comfort with medical supplies for Haiti in a day's notice

Getting the USNS Comfort stocked with needed supplies before it steamed out of the Baltimore harbor and headed for earthquake-stricken Haiti was a high priority for logisticians and acquisition specialists at the Defense Logistics Agency's supply center in Philadelphia.

3 Feb 2010

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Experts from the University of Pennsylvania School of Medicine are available to offer expert medical insight and commentary during the 2010 Winter Olympics in Vancouver on issues ranging from the effects of performance enhancing drugs to concerns about the spread of novel H1N1, head trauma and more.

3 Feb 2010

New study to understand the association of winter "cold-air pools" with poor air quality

At times this winter, the greater Salt Lake City area has harbored the most polluted air in the United States. Now, researchers from the University of Utah and other institutions are starting a three-year, $1.3 million study to better understand the winter weather "inversion" conditions frequently associated with poor air quality.

3 Feb 2010

Iodoprovidone exhibits safety and efficiency in management of malignant pleural effusion

In the USA each year, 200,000 cancer patients suffer from a malignant pleural effusion - development of excessive fluid (pleural effusion) in the chest. Several litres of such fluid can accumulate, and many patients suffer from significant breathlessness and distress. One in four patients with lung cancer, one in every three with breast cancer and most of the patients with mesothelioma will develop a malignant effusion.

3 Feb 2010

Hundred millions for biotech-licence

Apeiron Biologics AG (Apeiron) today announced the signing of an agreement granting GlaxoSmithKline (GSK) exclusive rights to APN01 (recombinant human Angiotensin Converting Enzyme 2, rhACE2), an enzyme biotherapeutic currently in Phase 1 development for the treatment of the Acute Respiratory Distress Syndrome (ARDS).

3 Feb 2010

New device to eliminate pathogenic bacteria and viruses

A revolutionary new device is being launched today with the technology to eradicate 99.9999% of pathogenic airborne and surface bacteria and viruses.

3 Feb 2010

NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology

NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.

3 Feb 2010

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Soligenix, Inc., a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.

3 Feb 2010

Hovione announces filing of new drug application in Japan for the influenza drug CS-8958

Hovione is announcing the filing of a new drug application in Japan by its licensee Daiichi Sankyo Company Ltd. for the influenza drug CS-8958, which is delivered using Hovione's TwinCaps(R) inhaler.

2 Feb 2010

CTS: More people are being admitted to Canadian hospitals each year with COPD

A review of Canadian data by the nation's leading lung specialists has provided the factual evidence to support what respirologists across the country have been suspecting for some time. Shockingly, more people are being admitted to Canadian hospitals each year with chronic obstructive pulmonary disease (COPD) than any other major chronic illness (including heart attacks) and that number has been increasing dramatically in recent years.

2 Feb 2010

Leapfrog Group urges hospitals to report infection rates for consumers’ benefit

For the first time, in 2009, The Leapfrog Group asked hospitals across the country on behalf of Leapfrog's purchaser members to publicly report their rates of one of the most common and deadly forms of hospital-acquired infections: central-line associated blood stream infections, or CLABSIs.

2 Feb 2010

Pandemic H1N1 influenza of swine origin has distinct means of transmission from seasonal flu

Current research suggests that pandemic H1N1 influenza of swine origin has distinct means of transmission from the seasonal flu, yet does not result in the pathogenic severity of avian flu viruses.

2 Feb 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Mycobacterium avium infection can result in three different kinds of illness in humans

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys' summer camp

Vaccination against seasonal influenza produces protective immune response in infants

Mandatory flu shot program increases vaccination rate to more than 98% in BJC HealthCare

Tough economy adds stress to hospitals; Community health centers help fill gaps

New York Times examines WHO process for getting H1N1 vaccines to countries in need

BD Diagnostics launches Be a Flu Fighter initiative to increase awareness and prevent influenza

DLA stocks USNS Comfort with medical supplies for Haiti in a day's notice

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

New study to understand the association of winter "cold-air pools" with poor air quality

Iodoprovidone exhibits safety and efficiency in management of malignant pleural effusion

Hundred millions for biotech-licence

New device to eliminate pathogenic bacteria and viruses

NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Hovione announces filing of new drug application in Japan for the influenza drug CS-8958

CTS: More people are being admitted to Canadian hospitals each year with COPD

Leapfrog Group urges hospitals to report infection rates for consumers’ benefit

Pandemic H1N1 influenza of swine origin has distinct means of transmission from seasonal flu

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in